SI1049468T1 - Uporaba praškastih pripravkov, ki vsebujejo hidroksipiridon, za zdravljenje golenskih razjed in preležanin - Google Patents

Uporaba praškastih pripravkov, ki vsebujejo hidroksipiridon, za zdravljenje golenskih razjed in preležanin

Info

Publication number
SI1049468T1
SI1049468T1 SI9930962T SI9930962T SI1049468T1 SI 1049468 T1 SI1049468 T1 SI 1049468T1 SI 9930962 T SI9930962 T SI 9930962T SI 9930962 T SI9930962 T SI 9930962T SI 1049468 T1 SI1049468 T1 SI 1049468T1
Authority
SI
Slovenia
Prior art keywords
ulcers
hydroxypyridones
utilization
preparations containing
powder preparations
Prior art date
Application number
SI9930962T
Other languages
English (en)
Slovenian (sl)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SI1049468T1 publication Critical patent/SI1049468T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9930962T 1998-01-24 1999-01-11 Uporaba praškastih pripravkov, ki vsebujejo hidroksipiridon, za zdravljenje golenskih razjed in preležanin SI1049468T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
EP99902528A EP1049468B1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren

Publications (1)

Publication Number Publication Date
SI1049468T1 true SI1049468T1 (sl) 2007-08-31

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930962T SI1049468T1 (sl) 1998-01-24 1999-01-11 Uporaba praškastih pripravkov, ki vsebujejo hidroksipiridon, za zdravljenje golenskih razjed in preležanin

Country Status (27)

Country Link
US (1) US6534528B1 (https=)
EP (1) EP1049468B1 (https=)
JP (1) JP5127091B2 (https=)
KR (1) KR100597332B1 (https=)
CN (1) CN1128619C (https=)
AR (1) AR016445A1 (https=)
AT (1) ATE360418T1 (https=)
AU (1) AU752406B2 (https=)
BR (1) BR9907734A (https=)
CA (1) CA2319359C (https=)
CY (1) CY1106684T1 (https=)
DE (2) DE19802708A1 (https=)
DK (1) DK1049468T3 (https=)
ES (1) ES2285829T3 (https=)
HR (1) HRP20000496A2 (https=)
HU (1) HU228824B1 (https=)
IL (1) IL137453A (https=)
ME (1) ME00390B (https=)
NZ (1) NZ505898A (https=)
PL (1) PL192550B1 (https=)
PT (1) PT1049468E (https=)
RS (1) RS50903B (https=)
RU (1) RU2212239C2 (https=)
SI (1) SI1049468T1 (https=)
SK (1) SK285350B6 (https=)
TR (1) TR200002118T2 (https=)
WO (1) WO1999037300A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
MX2013001095A (es) * 2010-07-27 2013-03-12 Clariant Finance Bvi Ltd Composiciones que comprenden peroxido de hidrogeno o sustancias donadoras de peroxido de hidrogeno.
ES2525388T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Utilización de hidroxipiridonas o de sus sales para la estabilización del peróxido de hidrógeno o de unas sustancias que ponen en libertad peróxido de hidrógeno
RS61907B1 (sr) 2015-04-06 2021-06-30 Subdomain Llc Polipeptidi koji sadrže de novo vezujući domen i njihova primena

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
EP0241918B1 (de) * 1986-04-18 1992-05-27 Hoechst Aktiengesellschaft 1-Hydroxy-2-pyridone, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten, sowie bei der Herstellung der 1-Hydroxy-2-pyridone gebildete Zwischenprodukte
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
DE59609219D1 (de) * 1995-12-04 2002-06-20 Aventis Pharma Gmbh Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen

Also Published As

Publication number Publication date
IL137453A (en) 2005-11-20
PL342055A1 (en) 2001-05-21
DE19802708A1 (de) 1999-07-29
DE59914312D1 (de) 2007-06-06
HUP0200851A1 (hu) 2002-07-29
EP1049468B1 (de) 2007-04-25
TR200002118T2 (tr) 2000-12-21
CN1128619C (zh) 2003-11-26
AU2278799A (en) 1999-08-09
DK1049468T3 (da) 2007-07-30
AR016445A1 (es) 2001-07-04
IL137453A0 (en) 2001-07-24
AU752406B2 (en) 2002-09-19
JP2002501020A (ja) 2002-01-15
RS50903B (sr) 2010-08-31
US6534528B1 (en) 2003-03-18
ATE360418T1 (de) 2007-05-15
SK285350B6 (sk) 2006-11-03
NZ505898A (en) 2002-06-28
CA2319359A1 (en) 1999-07-29
HRP20000496A2 (en) 2000-12-31
JP5127091B2 (ja) 2013-01-23
HUP0200851A3 (en) 2003-05-28
PT1049468E (pt) 2007-05-31
KR100597332B1 (ko) 2006-07-10
CA2319359C (en) 2008-03-18
HK1034447A1 (en) 2001-10-26
PL192550B1 (pl) 2006-11-30
EP1049468A1 (de) 2000-11-08
MEP55908A (en) 2011-05-10
ES2285829T3 (es) 2007-11-16
KR20010034325A (ko) 2001-04-25
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
BR9907734A (pt) 2000-10-17
SK10892000A3 (sk) 2000-12-11
YU43700A (sh) 2003-08-29
CN1288380A (zh) 2001-03-21
RU2212239C2 (ru) 2003-09-20
CY1106684T1 (el) 2012-05-23
HU228824B1 (en) 2013-05-28

Similar Documents

Publication Publication Date Title
AU4470397A (en) Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions
GB9404191D0 (en) Preparations and uses of polyferric sulphate
HU9702034D0 (en) Heterocyclic compounds of leukocita-adhesion-inhibitor and vla-4-antagonist activity
IL95642A0 (en) Topical preparations for treatment of ulcers and other lesions
PL342650A1 (en) Method of treating capsules and dry powdered pharmacological preparations
HU9302347D0 (en) Application of quinones for treatment of cancer and/or aids
SI1049468T1 (sl) Uporaba praškastih pripravkov, ki vsebujejo hidroksipiridon, za zdravljenje golenskih razjed in preležanin
AU1097192A (en) Treatment of particulate material
GB9519710D0 (en) Treatment of particulate material
IL116532A0 (en) 1-oxo-2-(phenylsulphonylamino) pentylpiperdine derivatives their preparation and their therapeutic application
HUP0101299A3 (en) Use of topiramate and derivatives for manufacturing medicament useful for treating schizophrenia
CS397389A3 (en) Mobile chair for lifting and transfer of invalids
EP0608511A3 (en) Utilization of lysolecithins in the treatment of male impotence and alopecia and the relevant compositions suitable for such use
LT97003A (en) Ointment for treatment of sunburns and wounds
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
HU9600916D0 (en) Tape family containing active compounds for treating and preventing skin diseases
EP1005355A4 (en) METHOD FOR THE TREATMENT OF GASTRIC Ulcers AND THE RELATED PRODUCTS
GB9715198D0 (en) Treatment and prophylaxis of infarction
GB9719596D0 (en) Treatment and prophylaxis of infarction
IL138881A0 (en) Use of organophosphorus compounds for therapeutic and prophylactic treatment of infection
GB9408914D0 (en) Treatment and pophylaxis of infarction
HUP9701020A3 (en) Wheelchair for transporting of invalids inside and/or outside
HU2058U (en) Wheelchair for transporting of invalids inside and/or outside
GB9815372D0 (en) Treatment of depression and pharmaceutical preparations therefor
PL347690A1 (en) Treatment of depression and pharmaceutical preparations therefor